Liver enzymes as a predictor of mortality in patients with COVID-19? A cross-sectional study.

Liver injury in patients with COVID-19 infection may directly result from viral infection of liver cells, immune-mediated inflammation such as cytokine storm, and hypoxia resulting from pneumonia. Additionally, liver injury may occur due to drug toxicity and may lead to liver failure in critically ill COVID-19 patients. Given the significance of the liver and its vulnerability in COVID-19 patients, this study aimed to investigate the correlation of serum liver enzymes with the prognosis of hospitalized COVID-19 patients at Imam Khomeini Hospital in Urmia.

Relationship between serum lactate dehydrogenase levels and prognosis in patients infected with omicron and delta variants of COVID-19: A cross-sectional study.

Determining the prognosis of COVID-19 is crucial for understanding disease trends and developing effective treatment strategies, particularly for severe cases. However, there is currently insufficient evidence regarding the role of lactate dehydrogenase (LDH) in COVID-19 and its prognostic implications. This retrospective cross-sectional study analyzed data from all patients hospitalized at Urmia Imam Khomeini Hospital between September 2021 and March 2023 with a diagnosis of COVID-19 involving the Delta and Omicron variants.

Mortality predictive value of APACHE II Scores in COVID-19 patients in the intensive care unit: a cross-sectional study.

Unlabelled: The Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring system was developed to predict hospital mortality, which can be used as a predictor of final hospital outcome in coronavirus disease 2019 (COVID-19) patients. Therefore, the present study was designed and conducted with the aim of determining the average APACHE II score in patients with COVID-19 patients.

Methods: In this cross-sectional study, patients with COVID-19 infection confirmed by PCR test were enrolled in the ICU of Imam Khomeini Hospital in Urmia city during 2020-2022.

Investigating the relationship between interleukin-6 serum levels and outcome in acute ischemic CVA.

Introduction: Interleukin-6 (IL-6) is among the inflammatory mediators exhibiting elevated levels in ischemic stroke (IS) patients. The present study set out to evaluate the relationship between serum levels of interleukin-6 with long-term and at-hospital outcomes of acute ischemic stroke in patients hospitalized at Imam Khomeini Hospital, Urmia, Iran, from 2017 to 2018.

Method And Materials: This cross-sectional descriptive study enrolled 29 and 31 acute stroke patients for long-term and at-hospital observation, respectively.